Science Explorer Back to mapMap
Discussion
Researcher · University Hospital Brno · Czechia

Jiřı́ Mayer

Jiřı́ Mayer publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and Lymphoma Diagnosis and Treatment.

ORCID 0000-0003-0567-9887 OpenAlex
World rank
#2,586,028
of 7,710,434 ranked researchers
Rank in Czechia
#6,231
of 39,303
Works
1,439
Citations
29k
Citations per work
20.2
h-index
70
i10-index 314Top 1.2% in Hematology
Jiřı́ Mayer

What does Jiřı́ Mayer research?

Jiřı́ Mayer's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (5%).

Health Sciences: 764 works · 53.1% of their workMedicine: 764 works · 53.1% of their workHematology: 271 works · 18.8% of their workGenetics: 265 works · 18.4% of their workPathology and Forensic Medicine: 119 works · 8.3% of their workOncology: 109 works · 7.6% of their workEverything else: 496 works · 34.5% of their workLife Sciences: 178 works · 12.4% of their workBiochemistry, Genetics and Molecular Biology: 102 works · 7.1% of their workMolecular Biology: 102 works · 7.1% of their workImmunology and Microbiology: 76 works · 5.3% of their workImmunology: 76 works · 5.3% of their workTHEIR WORKJiřı́ Mayer1,439works
Life Sciences12%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine76453.1%
  2. Everything else49634.5%
    1. Biochemistry, Genetics and Molecular Biology1027.1%
    2. Immunology and Microbiology765.3%
  1. 1Hematology19% of their works
  2. 2Genetics18% of their works
  3. 3Pathology and Forensic Medicine8% of their works
  4. 4Oncology8% of their works
  5. 5Molecular Biology7% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Jiřı́ Mayer's research?

The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL, Imatinib, Hematopoietic Stem Cells and Classification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors8573 topics
  2. Rituximab7942 topics
  3. Chronic Lymphocytic Leukemia5421 topic
  4. Genomic Aberrations5421 topic
  5. BCR-ABL2891 topic
  6. Imatinib2891 topic
  7. Hematopoietic Stem Cells2542 topics
  8. Classification2521 topic
  9. Lymphoma2521 topic
  10. Minimal Residual Disease2012 topics
  11. AML1831 topic
  12. Acute Myeloid Leukemia1831 topic
  13. Acute Lymphoblastic Leukemia1321 topic
  14. Childhood Cancer1321 topic
  15. Genetic Mutations901 topic
  16. Primary Immunodeficiency901 topic
  17. Bone Marrow Niche711 topic
  18. Graft-versus-Host Disease711 topic
  19. Diagnosis Criteria691 topic
  20. International Myeloma Working Group691 topic

Where does Jiřı́ Mayer work?

Jiřı́ Mayer's main affiliation in the publication record is University Hospital Brno, Czechia.

How many publications and citations does Jiřı́ Mayer have?

OpenAlex counts 1,439 works and 29,137 citations for Jiřı́ Mayer, an h-index of 70, ranking #2,586,028 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jiřı́ Mayer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.